"Nucleoside Deaminases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyze the hydrolysis of nucleosides with the elimination of ammonia.
Descriptor ID |
D009700
|
MeSH Number(s) |
D08.811.277.151.486
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleoside Deaminases".
Below are MeSH descriptors whose meaning is more specific than "Nucleoside Deaminases".
This graph shows the total number of publications written about "Nucleoside Deaminases" by people in this website by year, and whether "Nucleoside Deaminases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 3 | 1 | 4 |
2000 | 3 | 1 | 4 |
2001 | 2 | 0 | 2 |
2002 | 2 | 5 | 7 |
2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleoside Deaminases" by people in Profiles.
-
Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast. Biochemistry (Mosc). 2011 Jan; 76(1):131-46.
-
Basic and clinical immunology. J Allergy Clin Immunol. 2003 Mar; 111(3 Suppl):S813-8.
-
Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Mol Ther. 2002 Aug; 6(2):287-97.
-
Gene therapy for prostate cancer. Expert Rev Anticancer Ther. 2002 Jun; 2(3):309-21.
-
Prolonged stability and sustained prodrug cell killing activity using receptor-mediated delivery of malarial circumsporozoite-cytosine deaminase fusion protein into liver cancer cells. Mol Cancer Ther. 2002 May; 1(7):461-7.
-
Current progress in suicide gene therapy for cancer. World J Surg. 2002 Jul; 26(7):783-9.
-
High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 2002 Apr 15; 62(8):2337-42.
-
Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging. 2002 Jan-Mar; 1(1):36-42.
-
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):15-63.
-
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):65-100.